AUG Pharma listed on dragonforce ransomware leak site

• Ransomware group: dragonforce
• Country: Egypt
• Sector: Healthcare
• Announcement date: April 4, 2026

Egypt-based pharmaceutical company targeted by dragonforce

The Egypt-based pharmaceutical company AUG Pharma has been listed on the leak site of the dragonforce ransomware group. According to an announcement made on April 4, 2026, the group claims to have successfully targeted the organization, marking a significant potential breach for the healthcare entity.

Details of the claimed attack

The dragonforce group has listed data allegedly belonging to AUG Pharma on their leak platform. The group claims that the attack occurred on April 4, 2026, and asserts that approximately 890.34 GB of the company's data has been compromised. This massive volume of data suggests a substantial breach of the organization's digital environment.

The dragonforce group is identified as a structure that emerged in 2023. The group is reported to operate by providing infrastructure to affiliates, a model often seen in modern ransomware operations. This decentralized approach allows the group to facilitate attacks by offering the necessary technical tools and platforms for various affiliates to conduct their own malicious activities.

Data involvement and content

Regarding the specifics of the breach, the listing names no specific data types that have been compromised. While the group has claimed a significant volume of data, no specific details regarding the content of the allegedly leaked data have been provided. However, considering the company's pharmaceutical development and manufacturing operations, it is assessed that commercial and operational data may be included in the stolen information.

About AUG Pharma

AUG Pharma is an Egypt-based pharmaceutical company focused on the development, manufacturing, and commercialization of innovative pharmaceutical products. They offer various health solutions, including immune boosters, dermatological creams, and pain relief medications.

Impact assessment and industry implications

The leak claim may create negative impacts on the company's operational continuity and commercial reputation. As a company operating in the pharmaceutical sector, if the leaked data contains sensitive commercial information or supply chain data, secondary risks may increase. The group's structure of providing infrastructure to affiliates may increase the diversity and targeting of attacks.

In the broader context of cybersecurity, ransomware groups often use a